Cambrex’s Third-Quarter Profits Rise

Cambrex reported a 30% hike in third-quarter operating profits, to $3.5 million, on sales up 2.3%, to $54.7 million. The figures relate solely to ongoing businesses. Cambrex sold its biotechnology and biopharmaceuticals unit to Lonza in the past year. Lower...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers